Group letter: H.R. 3 limits innovation and decreases access to treatment options
Dear Senator Tester, Senator Daines, and Representative Rosendale, While you and your colleagues continue to search for a solution to high prescription drug costs, we urge you to protect patients access to medicine and innovative new treatments, and focus on directly addressing out-of-pocket costs. The recently introduced drug pricing proposal, H.R. 3 (Speaker Pelosi’s legislation), …
Group letter: H.R. 3 limits innovation and decreases access to treatment options Read More »